(Allergan plc)

	AGN latest price $218.8885 (-1.41%) ($218.2458 - $223.1052) on Thu. Aug. 17, 2017.
	Trend Analysis and Forecast
Average Daily Percentage Swing	0.92% (three month average)
RSI	3
Latest Price	$218.8885(-1.41%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.6% a day on average for past five trading days.
Weekly Trend	AGN declines -4.4% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(49%)    XBI(45%)    SPY(44%)    VT(44%)
Factors Impacting AGN price	AGN will decline at least -0.46% in a week (0% probabilities).   VIXM(-29%)    TLT(-18%)    UUP(-16%)    SHY(-3%)    GDXJ(-3%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.46% (StdDev 0.92%)
Hourly BBV	0 ()
Intraday Trend	-1.4%

Resistance Level	$235.93
5 Day Moving Average	$223.46(-2.05%)
10 Day Moving Average	$227.31(-3.7%)
20 Day Moving Average	$235.93(-7.22%)
To recent high	-12%
To recent low	3.1%
Market Cap	$72.168b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed